Literature DB >> 22525729

Diabetes: hyperfiltration-a risk factor for nephropathy in T1DM?

Christos Chatzikyrkou1, Hermann Haller.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22525729     DOI： 10.1038/nrendo.2012.63

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes.

Authors:  Ian H de Boer; Wanjie Sun; Patricia A Cleary; John M Lachin; Mark E Molitch; Michael W Steffes; Bernard Zinman
Journal:  N Engl J Med       Date:  2011-11-12       Impact factor: 91.245

Review 2.  The clinical significance of hyperfiltration in diabetes.

Authors:  G Jerums; E Premaratne; S Panagiotopoulos; R J MacIsaac
Journal:  Diabetologia       Date:  2010-05-23       Impact factor: 10.122

3.  Measured GFR does not outperform estimated GFR in predicting CKD-related complications.

Authors:  Chi-yuan Hsu; Kathleen Propert; Dawei Xie; Lee Hamm; Jiang He; Edgar Miller; Akinlolu Ojo; Michael Shlipak; Valerie Teal; Raymond Townsend; Matthew Weir; Jillian Wilson; Harold Feldman
Journal:  J Am Soc Nephrol       Date:  2011-09-15       Impact factor: 10.121

4.  Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes.

Authors:  Miwa Morita; Yasuko Uchigata; Ko Hanai; Yohei Ogawa; Yasuhiko Iwamoto
Journal:  Am J Kidney Dis       Date:  2011-07-16       Impact factor: 8.860

5.  Imprecision of creatinine-based GFR estimates in uninephric kidney donors.

Authors:  Jane C Tan; Bing Ho; Stephan Busque; Kristina Blouch; Geraldine Derby; Bradley Efron; Bryan D Myers
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-28       Impact factor: 8.237

6.  Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria.

Authors:  Marcello Tonelli; Scott W Klarenbach; Anita M Lloyd; Matthew T James; Aminu K Bello; Braden J Manns; Brenda R Hemmelgarn
Journal:  Kidney Int       Date:  2011-08-17       Impact factor: 10.612

7.  Hyperfiltration in type 1 diabetes: does it exist and does it matter for nephropathy?

Authors:  M C Thomas; J L Moran; V Harjutsalo; L Thorn; J Wadén; M Saraheimo; N Tolonen; J Leiviskä; A Jula; C Forsblom; P H Groop
Journal:  Diabetologia       Date:  2012-02-10       Impact factor: 10.122

8.  Renal and retinal effects of enalapril and losartan in type 1 diabetes.

Authors:  Michael Mauer; Bernard Zinman; Robert Gardiner; Samy Suissa; Alan Sinaiko; Trudy Strand; Keith Drummond; Sandra Donnelly; Paul Goodyer; Marie Claire Gubler; Ronald Klein
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

9.  In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

Authors:  Bruce A Perkins; Linda H Ficociello; Bijan Roshan; James H Warram; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2010-01       Impact factor: 10.612

10.  Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria.

Authors:  Michael L Merchant; Bruce A Perkins; Grzegorz M Boratyn; Linda H Ficociello; Daniel W Wilkey; Michelle T Barati; Clinton C Bertram; Grier P Page; Brad H Rovin; James H Warram; Andrzej S Krolewski; Jon B Klein
Journal:  J Am Soc Nephrol       Date:  2009-07-30       Impact factor: 10.121
  10 in total
  2 in total

1.  Correlation of Microalbuminuria with Estimated GFR (eGFR) by Cockcroft-Gault and MDRD Formula in Type 2 Diabetics and Hypertensives.

Authors:  T K Saha; Arabinda Mohan Bhattarai; H S Batra; Mithu Banerjee; Pratibha Misra; Vivek Ambade
Journal:  Indian J Clin Biochem       Date:  2014-05-11

2.  Incidence and Mortality Rates and Clinical Characteristics of Type 1 Diabetes among Children and Young Adults in Cochabamba, Bolivia.

Authors:  Elizabeth Duarte Gómez; Gabriel Andrew Gregory; Miriam Castrati Nostas; Angela Christine Middlehurst; Alicia Josephine Jenkins; Graham David Ogle
Journal:  J Diabetes Res       Date:  2017-08-29       Impact factor: 4.011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.